Guest post by Sara Jane Demy, CEO, Demy-Colton Life Science Advisors
With the unofficial arrival of Fall comes the time to dust the sand off our feet and focus on getting deals done before the end of the year and, of course, making your plans to be in San Francisco during the second week of January.
The impressive performance of the biotech industry has survived the recent market turmoil, and most investors are confident that the next few months will see a steady stream of IPOs and a healthy level of private investment that is fueled, in part, by those exits. So we expect the atmosphere at 2016’s Biotech Showcase™ to be upbeat and filled with promise.
This year we are expanding the scope of Biotech Showcase to include medtech and digital medicine. We have realized more and more medtech investors are drawn to San Francisco for events in January, so we are happy to be able to accommodate the MedTech Showcase for the first time on Tuesday, January 12.
We are also developing a Digital Medicine Showcase which will take place January 13. Digital technology is transforming healthcare and attracting record levels of investment. With more than USD 4 billion of investment going into the space in 2014, we thought it was important that we bring these opportunities to our audience.
We are excited about the opportunity to expand our program to address the needs of investors targeting the evolving life sciences ecosystem. And, as always, we look forward to seeing you in San Francisco in January.